After demonstrating that CD40L+CD8+ T cells target CD40+TAg+ cancer cells directly, inducing cell death through a CD40L-CD40 interaction, we sought to extend our investigation to another in vivo cancer cell model. The gene discussed is CD8A; the disease is cancer.